Impax Asset Management Group’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32.7M | Buy |
294,613
+10,607
| +4% | +$1.18M | 0.19% | 89 |
|
2025
Q1 | $31.8M | Sell |
284,006
-96,564
| -25% | -$10.8M | 0.19% | 91 |
|
2024
Q4 | $35.2M | Buy |
380,570
+212,828
| +127% | +$19.7M | 0.16% | 98 |
|
2024
Q3 | $14.1M | Sell |
167,742
-7,979
| -5% | -$669K | 0.06% | 136 |
|
2024
Q2 | $12.1M | Buy |
175,721
+49,920
| +40% | +$3.43M | 0.05% | 147 |
|
2024
Q1 | $9.21M | Sell |
125,801
-37,289
| -23% | -$2.73M | 0.04% | 178 |
|
2023
Q4 | $13.2M | Sell |
163,090
-327
| -0.2% | -$26.5K | 0.05% | 152 |
|
2023
Q3 | $12.2M | Buy |
163,417
+53,704
| +49% | +$4.02M | 0.05% | 141 |
|
2023
Q2 | $8.46M | Buy |
109,713
+668
| +0.6% | +$51.5K | 0.03% | 177 |
|
2023
Q1 | $9.05M | Buy |
109,045
+69,533
| +176% | +$5.77M | 0.04% | 161 |
|
2022
Q4 | $3.39M | Buy |
39,512
+2
| +0% | +$172 | 0.02% | 200 |
|
2022
Q3 | $2.44M | Sell |
39,510
-887
| -2% | -$54.7K | 0.01% | 215 |
|
2022
Q2 | $2.5M | Sell |
40,397
-4,047
| -9% | -$250K | 0.01% | 220 |
|
2022
Q1 | $2.64M | Buy |
44,444
+2,986
| +7% | +$178K | 0.01% | 229 |
|
2021
Q4 | $3.01M | Buy |
41,458
+1,257
| +3% | +$91.3K | 0.01% | 220 |
|
2021
Q3 | $2.81M | Buy |
40,201
+149
| +0.4% | +$10.4K | 0.01% | 225 |
|
2021
Q2 | $2.76M | Sell |
40,052
-17
| -0% | -$1.17K | 0.01% | 225 |
|
2021
Q1 | $2.59M | Buy |
40,069
+1,996
| +5% | +$129K | 0.01% | 223 |
|
2020
Q4 | $2.22M | Buy |
38,073
+3,189
| +9% | +$186K | 0.01% | 200 |
|
2020
Q3 | $2.2M | Buy |
34,884
+1,067
| +3% | +$67.4K | 0.02% | 194 |
|
2020
Q2 | $2.6M | Buy |
33,817
+874
| +3% | +$67.2K | 0.03% | 191 |
|
2020
Q1 | $2.46M | Buy |
32,943
+5,361
| +19% | +$401K | 0.03% | 183 |
|
2019
Q4 | $1.79M | Buy |
+27,582
| New | +$1.79M | 0.02% | 199 |
|